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Introduction
Prostate cancer constitutes 29% of  all cancer cases and 
9% of  all cancer deaths in the United States. Currently, an 
estimated 91% of  new cases of  prostate cancer are diag-
nosed at local or regional stages, for which the five-year 
relative survival approaches 100%. Increased screening 
through prostate-specific antigen (PSA) testing has resulted 
in an increased rate of  diagnosis of  prostate cancer (1) and 
a considerable stage migration toward a higher proportion 
of  localized tumors (2). 
Bone metastasis is frequent, and is a serious and costly 
complication of  cancer with an unknown exact annual in-
cidence in the United States in patients with advanced 
prostate cancer. Once tumor metastasizes to bone, it is usu-
ally incurable (3). Metastatic bone lesions from cancer are 
generally multiple and osteoblastic (4); only approximately 
10% are solitary (5). Bone metastases are more frequent in 
patients with high PSA levels and poorly differentiated tu-
mors at biopsy, regardless of  the patient’s age (6). Presenta-
tion of  a pure osteolytic and solitary metastasis from a pros-
tate carcinoma is extremely rare. There are a handful of  
reports of  solitary osteoblastic bone lesions due to adeno-
carcinoma of  the prostate. However, to our knowledge, 
only one other case of  a solitary osteolytic bone metastasis 
has been reported from a prostatic primary, and it was lo-
cated in the radial head (5). Brown et al also reported a 
solitary osteolytic bone lesion of  the mandible in 1965, 
which was suspected to originate from a prostate carci-
noma; however, this was never proved by a tissue biopsy (7). 
Our case of  prostate cancer presented with clinical symp-
toms of  a solitary metastasis to the right hip. The combina-
tion of  multiple radiologic studies such as plane x-rays, CT 
images, and MRI means that it is now possible to detect a 
solitary lesion with no other lesion very accurately. To the 
best of  our knowledge, this is the first case report of  an 
osteolytic solitary hip lesion that is a metastasis from pros-
tate carcinoma. 
Case report
A 70-year-old man was admitted to our hospital with a 
four-month history of  gradually progressive severe right hip 
pain and stiffness, restricting physical activities and walking. 
Both passive and active movements aggravated the pain, 
causing a complete restriction in walking. The patient de-
nied any urinary symptom. Past medical history included 
type II diabetes mellitus, atrial fibrillation, hypercholestro-
lemia, COPD, and coronary artery disease. The patient’s 
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family history was significant for a history of  unknown type 
of  cancers; his father died of  such a cancer at the age of  
45. Significant findings on physical examination included 
tenderness over the anterolateral region of  the right upper 
thigh. The prostate was mildly enlarged and appeared to be 
smooth, normal in texture, and with no nodules by digital 
rectal exam. Laboratory data revealed a normal complete 
blood count and chemistry panel. Alkaline phosphatase was 
elevated at 210 U/L. A plain AP-view radiograph of  the 
pelvis and right hip showed a osteolytic lesion in the supe-
rior aspect of  the right femoral head (Fig. 1). 
Whole-body bone scanning revealed a solitary focus of  
abnormal intense radiotracer uptake within the interotro-
chanteric region of  the right hip as well as the head of  the 
right femur (Fig. 2). 
MRI imaging of  the right hip pre- and post-gadolinium 
administration revealed markedly hypointense signal within 
the head, the intertrochanteric portion, and the proximal 
shaft of  the right femur on T1- and T2-weighted se-
quences. This suggested lytic destructive bone lesions due 
to a malignancy (Fig. 3). 
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Figure 1. 70-year-old male with prostate carcinoma. AP 
radiograph of the proximal right femur, showing an ill-
defined osteolytic lesion of the right femoral neck and inter-
trochanteric ridge.
Figure 2. 70-year-old male with prostate carcinoma. Radio-
nuclide bone scan of the pelvis and right femur, revealing a 
solitary focus of abnormal intense radiotracer uptake within 
the interotrochanteric region of the right hip as well as the 
head of the right femur.
Figure 3. 70-year-old male with prostate carcinoma. Co-
ronal T1-weighted MR image of the lower pelvis, showing 
abnormally decreased T1 signal in the right proximal femur, 
indicating marrow fat replacement with tumor. 
CT confirmed the presence of  a single lytic lesion of  the 
right femoral neck with a partially sclerotic margin (Fig. 4). 
Tumor marker studies revealed an elevated level of  PSA 
at 174 ng/ml. A transrectal ultrasound-guided prostate 
needle biopsy revealed prostate adenocarcinoma, with 
Gleason’s score of  3+4=7, involving multiple cores; ap-
proximately 50% of  the total prostatic tissue and immu-
nostain was positive for PSA. The patient was started on 
LHRH-agonist, Goserelin, along with antiandrogen Bicalu-
tamide and radiation therapy. The patient was clinically 
doing fine; however, he sustained a massive pulmonary em-
bolism on the 30th day of  admission and unexpectedly 
expired.
Discussion
Prostate cancer is the most common malignancy in males 
over 50 years of  age (5) and the second most common 
cause of  cancer-associated mortality in the United States 
and Western Europe (6). Most newly diagnosed patients 
with prostate carcinoma are asymptomatic and have mod-
erately differentiated and organ-confined disease. This mi-
gration has been attributed primarily to the impact of  
widespread prostate carcinoma screening initiatives (2).
Bone metastasis occurs in up to 70% of  patients with 
advanced prostate cancer (3); approximately 30% of  the 
cases have bone metastasis at the time of  diagnosis. Cancer 
cells spread to bone by direct extension, arterial emboliza-
tion, or venous dissemination (4). Data have confirmed that 
bone metastases are more frequent in patients with high 
prostate-specific antigen (PSA) levels and poorly differenti-
ated tumors at biopsy, regardless of  the patient’s age (6). 
The pretreatment level of  PSA is the most important pre-
dictor of  recurrence after radiotherapy (8). Overproduction 
of  urokinase-type plasminogen activator (u-PA) by prostate-
cancer cells increases bone metastasis. PSA can also cleave 
parathyroid hormone-related peptide at the N-terminal, 
which could block tumor-induced bone resorption. It may 
also activate osteoblastic growth factors, released in the 
bone microenvironment during the development of  bone 
metastases (3). Bone scintigraphy is the most sensitive and 
commonly used technique for detecting skeletal metastases 
(9); the finding of  multiple areas of  increased uptake is di-
agnostic of  metastatic disease (4). Metastatic tumors of  
prostate carcinoma in bone are generally multiple (5) and 
are of  two distinct types; osteoblastic or osteolytic, or occa-
sionally mixed (3), with the osteoblastic type of  lesion oc-
curring more frequently (7).
Skeletal complications from bone metastases include 
pathologic fractures, hypercalcemia, severe bone pain, and 
spinal cord compression. Cord compression occurs in ap-
proximately 7% of  patients with prostate cancer and can 
lead to paraplegia, if  surgical intervention is not performed 
immediately. Skeletal complications contribute to the ero-
sion of  quality of  life in prostate cancer patients (10).
Brown et al reported two cases of  solitary metastatic 
mandible cancer, suspected to be of  prostatic origin. The 
nature of  these lesions has not been mentioned in these 
reported articles (7). Ansari et al for the first time reported 
osteolytic solitary radial head metastases from prostate can-
cer in a 60-year old male (5).
Pure osteolytic lesions may occur, but are less common. 
Solitary expansile metastases in prostate carcinoma patients  
are a rare clinical presentation (5).
Acknowledgments
We gratefully acknowledge the help of  Jeff  Stevenson, 
who helped with MR spectroscopic analysis.
References
1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ: 
Cancer Statistics. CA Cancer J Clin 2007;57:43–66. 
[PubMed]
2. 	 Miller DC, Hafez KS, Stewart A, Montie JE, Wei JT: 
Prostate Carcinoma Presentation, Diagnosis, and Stag-
ing. Cancer 2003;98(6):1169-78 [PubMed]
3. 	 Roodman GD: Mechanisms of  Bone Metastasis. 
NEJM 2004;350(16):1655-64. [PubMed]
4 	 Robey EL, Schellhammer PF: Solitary lesions on bone 
scan in genitourinary malignancy. J Urol 
1984;132(5):1000-2. [PubMed]
5 	 Ansari MS, Nabi G, Aron M: Solitary Radial Head 
Metastasis with Wrist Drop: A Rare Presentation of  
Metastatic Prostate Carcinoma. Urol Int 
2003;70(1):77-9. [PubMed]
6  Salonia A, Gallina A, Camerota TC, Picchio M, Da-
Pozzo MFLF, Guazzoni G, Fazio F, Rigatti P, Montorsi 
F: Bone metastases are infrequent in patients with 
newly diagnosed prostate cancer: Analysis of  their 
clinical and pathologic features. 
Urology 2006;68(2):362-6. [PubMed]
7 	 Brown WF, Masson JK, Harrison EG Jr, McConahey 
WM: Solitary Metastatic Cancer of  the Mandible: 
three Cases with Apercalcemia. Mayo Clin Proc 
1965;40:392-6. [PubMed]
8 	 Roach III M, Weinberg V, Sandler, H, Thompson I: 
Staging for prostate cancer: time to incorporate pre-
Prostate carcinoma, presenting with a solitary osteolytic bone lesion to the right hip
RCR Radiology Case Reports | radiology.casereports.net 3 2009 | Volume 4 | Issue 4  
Figure 4. 70-year-old male with prostate carcinoma. Axial 
CT scan of the pelvis, showing mixed osteolytic lesion with 
sclerotic margins in right femoral neck.
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